Alehagen U - Search Results

1

Brain natriuretic peptide-guided treatment does not improve morbidity and mortality in extensively treated patients with chronic heart failure: responders to treatment have a significantly better outcome.

Karlström P, Alehagen U, Boman K, Dahlström U; UPSTEP-study group. Karlström P, et al. Among authors: alehagen u. Eur J Heart Fail. 2011 Oct;13(10):1096-103. doi: 10.1093/eurjhf/hfr078. Epub 2011 Jun 29. Eur J Heart Fail. 2011. PMID: 21715446 Free article. Clinical Trial.

2

Utility of the amino-terminal fragment of pro-brain natriuretic peptide in plasma for the evaluation of cardiac dysfunction in elderly patients in primary health care.

Alehagen U, Lindstedt G, Eriksson H, Dahlström U. Alehagen U, et al. Clin Chem. 2003 Aug;49(8):1337-46. doi: 10.1373/49.8.1337. Clin Chem. 2003. PMID: 12881450

3

[Usefulness of BNP in heart failure. Shortages of a current review reflect th complexity of the problem].

Lindstedt G, Alehagen U, Dahlström U. Lindstedt G, et al. Among authors: alehagen u. Lakartidningen. 2004 Feb 19;101(8):688-9. Lakartidningen. 2004. PMID: 15024944 Swedish. No abstract available.

4

Elevated circulating levels of thioredoxin and stress in chronic heart failure.

Jekell A, Hossain A, Alehagen U, Dahlström U, Rosén A. Jekell A, et al. Among authors: alehagen u. Eur J Heart Fail. 2004 Dec;6(7):883-90. doi: 10.1016/j.ejheart.2004.03.003. Eur J Heart Fail. 2004. PMID: 15556050 Free article.

5

Elevated D-dimer level is an independent risk factor for cardiovascular death in out-patients with symptoms compatible with heart failure.

Alehagen U, Dahlström U, Lindahl TL. Alehagen U, et al. Thromb Haemost. 2004 Dec;92(6):1250-8. doi: 10.1160/TH04-05-0278. Thromb Haemost. 2004. PMID: 15583730

6

The risk of cardiovascular death in elderly patients with possible heart failure. Results from a 6-year follow-up of a Swedish primary care population.

Alehagen U, Lindstedt G, Levin LA, Dahlström U. Alehagen U, et al. Int J Cardiol. 2005 Apr 8;100(1):17-27. doi: 10.1016/j.ijcard.2004.03.031. Int J Cardiol. 2005. PMID: 15820281

7

Risk of cardiovascular death in elderly patients with possible heart failure. B-type natriuretic peptide (BNP) and the aminoterminal fragment of ProBNP (N-terminal proBNP) as prognostic indicators in a 6-year follow-up of a primary care population.

Alehagen U, Lindstedt G, Levin LA, Dahlström U. Alehagen U, et al. Int J Cardiol. 2005 Apr 8;100(1):125-33. doi: 10.1016/j.ijcard.2004.10.006. Int J Cardiol. 2005. PMID: 15820295

8

[Pro: Natriuretic peptides as diagnostic tool. The analysis should be a routine in heart failure diagnosis].

Dahlström U, Alehagen U. Dahlström U, et al. Among authors: alehagen u. Lakartidningen. 2006 Mar 22-28;103(12):927-9. Lakartidningen. 2006. PMID: 16618036 Review. Swedish. No abstract available.

9

Reference intervals and decision limits for B-type natriuretic peptide (BNP) and its precursor (Nt-proBNP) in the elderly.

Alehagen U, Goetze JP, Dahlström U. Alehagen U, et al. Clin Chim Acta. 2007 Jul;382(1-2):8-14. doi: 10.1016/j.cca.2007.03.005. Epub 2007 Mar 14. Clin Chim Acta. 2007. PMID: 17433809

10

Natriuretic peptide biomarkers as information indicators in elderly patients with possible heart failure followed over six years: a head-to-head comparison of four cardiac natriuretic peptides.

Alehagen U, Svensson E, Dahlström U. Alehagen U, et al. J Card Fail. 2007 Aug;13(6):452-61. doi: 10.1016/j.cardfail.2007.03.002. J Card Fail. 2007. PMID: 17675059

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters